Skip to main content

Loading market data...

KRYS

Krystal Biotech, Inc.

NASDAQ • United states

$322.95

-$2.47

(-0.76%)

Source: Yahoo Finance · Quote time Oct 21, 2026 17:48 GMT+0000

Management
Credibility
Score

Krystal Biotech, Inc. (KRYS)

Unavailable

Quotes may be delayed

$9.56B

Market Cap

197,890

Volume

39.6

P/E Ratio

Unavailable

Div Yield

Krystal Biotech, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 2100 WHARTON STREET, PITTSBURGH, PA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

15 Oct 2026

Krystal Biotech, Inc. reported Regulation FD disclosure

Krystal Biotech, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

3 Aug 2026

Krystal Biotech, Inc. reported Operating or financial results

Krystal Biotech, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

3 Aug 2026

Krystal Biotech, Inc. filed Form 10-Q

Krystal Biotech, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

22 Jul 2026

Krystal Biotech, Inc. reported Another company event

Krystal Biotech, Inc. filed an 8-K covering another company event, supporting financial statements or exhibits.

20 May 2026

Krystal Biotech, Inc. reported Shareholder voting results

Krystal Biotech, Inc. filed an 8-K covering shareholder voting results.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$427.74M

Total assets (USD)$1.50B

Total liabilities (USD)$141.52M

Shareholders' equity (USD)$1.36B

Long-term debt (USD)$4.25M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$119.22M	$58.42M	$54.77M	$1.79	10-Q · 3 Aug 2026
Q1 2026	$116.36M	$53.69M	$55.93M	$1.83	10-Q · 4 May 2026
Q4 2025	$107.11M	$44.27M	$51.40M	Unavailable	10-K · 17 Feb 2026
Q3 2025	$97.80M	$41.37M	$79.37M	$2.66	10-Q · 3 Nov 2025
Q2 2025	$96.04M	$39.40M	$38.33M	$1.29	10-Q · 4 Aug 2025
Q1 2025	$88.18M	$36.25M	$35.73M	$1.20	10-Q · 6 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $403.50

24.9% upside potential

📈

Strong Buy

Unavailable

👍

Buy

7

⏸️

Hold

1

📉

Sell

0

8 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 17:49 UTC Targets range 361.00–441.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

4

Sep 2026

Krishnan Suma

Director, President, R&D, 10% owner

Open-market sale

$359.32 per share

25,000 shares

4

Sep 2026

Krishnan Krish S

Director, President and CEO, 10% owner

Open-market sale

$359.32 per share

25,000 shares

Top Shareholders

Fmr Llc

4,418,197 shares

1.011% change

6/30/2026

Blackrock, Inc.

4,181,432 shares

6.115% change

6/30/2026

Avoro Capital Advisors Llc

2,888,888 shares

0% change

6/30/2026

Vanguard Group Inc

2,778,845 shares

-0.479% change

12/31/2025

Vanguard Portfolio Management Llc

1,574,905 shares

8.113% change

6/30/2026

State Street Corp

1,351,158 shares

2.794% change

6/30/2026

Vanguard Capital Management Llc

1,240,567 shares

6.457% change

6/30/2026

Soleus Capital Management, L.P.

939,254 shares

-18.544% change

6/30/2026

Capital World Investors

777,843 shares

-5.684% change

6/30/2026

Vestor Capital, Llc

700,914 shares

350357% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 17:49 UTC· 14 hours ago

Research coverage and investment tools

Krystal Biotech, Inc. (KRYS) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). Its last price was US$322.95 on 21 Oct 2026. That is 70% of the way from its 52-week low of US$183.03 to its 52-week high of US$382.54. Its market capitalisation was US$9.56 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$119.22M	$58.42M	$54.77M	$1.79	—	49.0%	$71.22M	10-Q · 3 Aug 2026 (opens in a new tab)
Q1 2026	$116.36M	$53.69M	$55.93M	$1.83	—	46.1%	$73.23M	10-Q · 4 May 2026 (opens in a new tab)
Q4 2025	$107.11M	$44.27M	$51.40M	Unavailable	—	41.3%	$75.37M	10-K · 17 Feb 2026 (opens in a new tab)
Q3 2025	$97.80M	$41.37M	$79.37M	$2.66	—	42.3%	$37.96M	10-Q · 3 Nov 2025 (opens in a new tab)
Q2 2025	$96.04M	$39.40M R (restated)	$38.33M	$1.29	—	41.0%	$50.83M	10-Q · 4 Aug 2025 (opens in a new tab)
Q1 2025	$88.18M	$36.25M R (restated)	$35.73M	$1.20	—	41.1%	$24.77M	10-Q · 6 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/3/2026	$1.79	$1.70	+5.3%
Mar 2026	5/4/2026	$1.83	$1.45	+26.2%
Dec 2025	2/17/2026	$1.70	$1.62	+4.9%
Sep 2025	11/3/2025	$2.66	$1.12	+137.5%

Cash and equivalents: $427.74M
Total assets: $1.50B
Total liabilities: $141.52M
Shareholders' equity: $1.36B
Long-term debt: $4.25M

8-K · 15 Oct 2026

Krystal Biotech, Inc. reported Regulation FD disclosure (opens in a new tab)

Krystal Biotech, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 3 Aug 2026

Krystal Biotech, Inc. reported Operating or financial results (opens in a new tab)

Krystal Biotech, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
10-Q · 3 Aug 2026

Krystal Biotech, Inc. filed Form 10-Q (opens in a new tab)

Krystal Biotech, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 22 Jul 2026

Krystal Biotech, Inc. reported Another company event (opens in a new tab)

Krystal Biotech, Inc. filed an 8-K covering another company event, supporting financial statements or exhibits.
8-K · 20 May 2026

Krystal Biotech, Inc. reported Shareholder voting results (opens in a new tab)

Krystal Biotech, Inc. filed an 8-K covering shareholder voting results.

Insider	Date	Transaction	Shares	Average price	Filing
Krishnan Suma Director, President, R&D, 10% owner	4 Sep 2026	Open-market sale (S)	−25,000	$359.32	Form 4 (opens in a new tab)
Krishnan Krish S Director, President and CEO, 10% owner	4 Sep 2026	Open-market sale (S)	−25,000	$359.32	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Fmr Llc	6/30/2026	4,418,197	1.011%
Blackrock, Inc.	6/30/2026	4,181,432	6.115%
Avoro Capital Advisors Llc	6/30/2026	2,888,888	0%
Vanguard Group Inc	12/31/2025	2,778,845	-0.479%
Vanguard Portfolio Management Llc	6/30/2026	1,574,905	8.113%
State Street Corp	6/30/2026	1,351,158	2.794%
Vanguard Capital Management Llc	6/30/2026	1,240,567	6.457%
Soleus Capital Management, L.P.	6/30/2026	939,254	-18.544%
Capital World Investors	6/30/2026	777,843	-5.684%
Vestor Capital, Llc	6/30/2026	700,914	350357%

Previous close: 325.42 USD
Day range: 320.18 – 327.35 USD
52-week range: 183.03 – 382.54 USD
Volume: 197,890
Market cap: $9.56B
Average volume: 251,504
P/E ratio: 39.6
EPS (FY 2025, diluted): 6.84 USD
Shares outstanding: 29.60M
Beta (5Y monthly): 0.65

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 17:48 UTC· 14 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:37 UTC· 1 hour ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for KRYS yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.